Molecular analysis of APC promoter methylation and protein expression in colorectal cancer metastasis

Carcinogenesis
Jie ChenMatthias P A Ebert

Abstract

APC (adenomatous polyposis coli) promoter methylation has been linked to the early development of colorectal cancers. However, the role of APC methylation and its effect on protein expression in colon cancer metastasis is largely unknown. In this study, we investigated APC promoter methylation by Methylight analysis and analysed the APC protein levels by immunohistochemistry and western blot analysis in 24 liver metastasis and 39 primary colorectal cancers. Promoter methylation of the APC gene was found to be a frequent event in liver metastasis (10/24) and significantly more frequent compared with primary colorectal cancer (7/39, P = 0.047). APC methylation was not found in 14 matched normal colon tissues. APC protein was detected in the cytoplasm of primary and metastatic cancer cells and non-tumorous colon epithelium. By western blot analysis, APC protein levels were found to be decreased in primary tumour tissues compared with the normal colon mucosa. In contrast, APC protein levels were not decreased in the cancer cells that had metastasized to the liver. APC protein levels were independent of the presence of APC promoter methylation or gene mutations. In summary, APC promoter methylation is a frequent epigenetic alteratio...Continue Reading

References

Aug 9, 1991·Science·K W KinzlerD McKechnie
Jan 1, 1996·Nucleic Acids Research·C Béroud, T Soussi
Mar 17, 1997·International Journal of Cancer. Journal International Du Cancer·M O HiltunenJ Jänne
Feb 13, 1999·Nature Genetics·P A Jones, P W Laird
Mar 24, 2000·Trends in Genetics : TIG·S B Baylin, J G Herman
Mar 29, 2000·Nucleic Acids Research·C A EadsP W Laird
Mar 21, 2001·Human Molecular Genetics·N S FearnheadW F Bodmer
Dec 19, 2001·The Journal of Pathology·Manel Esteller, James G Herman
May 2, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthias P A EbertPeter Malfertheiner

❮ Previous
Next ❯

Citations

Nov 2, 2007·Journal of Cancer Research and Clinical Oncology·Antal CsepregiMatthias P A Ebert
Jun 15, 2011·BMC Cancer·Ewelina Stoczynska-FidelusPiotr Rieske
Aug 11, 2012·Journal of Preventive Medicine and Public Health = Yebang Ŭihakhoe Chi·Ho-Jin KangYoung-Seoub Hong
Feb 28, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Bi-Cheng YongJing-Nan Shen
Mar 27, 2018·The British Journal of Surgery·S YamashitaJ-N Vauthey
Mar 25, 2009·Genetic Testing and Molecular Biomarkers·Shee-Ping ChenHorng-Jyh Harn
Jun 16, 2016·Nature Communications·Michael J SchellTimothy J Yeatman
Jan 22, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Takako KawasakiShuji Ogino
Feb 28, 2009·Journal of Cellular Physiology·Ludek StrasákStanislav Kozubek
Feb 6, 2010·Cancer Metastasis Reviews·Myoung Sook KimDavid Sidransky
Apr 26, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Othman Abdulla Al-ShabanahSalem Saleh Al-Rejaie
Oct 4, 2011·Journal of Biomolecular Screening·Jason M FoulksSteven B Kanner
Feb 19, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Aga Syed Sameer
Aug 7, 2017·Oncology Letters·Bing-Qiang LiCai-Hua Zhang
Apr 25, 2015·Experimental Biology and Medicine·Christina MichailidiConstantinos Troungos
Nov 8, 2018·BMC Cancer·Hassan AshktorabHassan Brim
Nov 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Viola SchmiemannHans Juergen Grote
Mar 17, 2011·The American Journal of Pathology·Hai-Xing JuYutaka Kondo
Oct 13, 2021·Molecular Biology Reports·Sacide PehlivanMustafa Pehlivan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.